347 results in Exploration of Targeted Anti-tumor Therapy
Latest
  • Latest
  • Most Viewed
  • Most Downloaded
  • Most Cited
Sort by :
Open Access Case Report
Immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in lung cancer: a case series
Abdul Wali Khan ... Dhruv Bansal
Published: November 12, 2025 Explor Target Antitumor Ther. 2025;6:1002347
85 9 0
Open Access Review
Metal grafted graphene-based nanomaterials towards cancer theranostic efficacy
Prashant H. Gohil, Gopal Avashthi
Published: November 10, 2025 Explor Target Antitumor Ther. 2025;6:1002346
136 18 0
Open Access Original Article
Racial disparities in hepatocellular carcinoma: a TCGA-based gene expression study of Caucasian and Asian populations
Muhammad Rezki Rasyak ... Caecilia Sukowati
Published: November 02, 2025 Explor Target Antitumor Ther. 2025;6:1002344
407 17 0
Open Access Retraction
Retraction: Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies
Editorial Office
Published: October 28, 2025 Explor Target Antitumor Ther. 2025;6:1002343
233 9 0
Open Access Original Article
Differential molecular mechanisms of bortezomib sensitization to rhTRAIL in non-small cell lung cancer cell lines
Paweł Kochany ... Frank A.E. Kruyt
Published: October 28, 2025 Explor Target Antitumor Ther. 2025;6:1002342
429 18 0
Open Access Review
New approaches of green silver nanoparticles for cancer and biomedical applications: a review
Puja Kumari ... Md Sabir Alam
Published: October 23, 2025 Explor Target Antitumor Ther. 2025;6:1002341
834 48 0
Open Access Original Article
Synergistic anticancer efficacy of optimized curcumin-piperine loaded magnetic nanoparticles for the treatment of colorectal cancer
Ritika Puri, Vimal Arora
Published: October 20, 2025 Explor Target Antitumor Ther. 2025;6:1002340
548 18 0
Open Access Review
Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress
Heayyean Lee ... Jeehoo Lee
Published: October 12, 2025 Explor Target Antitumor Ther. 2025;6:1002339
1009 16 0
Open Access Review
Next-generation cancer vaccines: targeting cryptic and non-canonical antigens for precision immunotherapy
Anu Shibi Anilkumar ... Ramakrishnan Veerabathiran
Published: September 25, 2025 Explor Target Antitumor Ther. 2025;6:1002338
This article belongs to the special issue Cancer Vaccines: From Basic Innovations to Clinical Translation
722 23 0
Open Access Review
Metabolic plasticity drives specific mechanisms of chemotherapy and targeted therapy resistance in metastatic colorectal cancer
Mariam Rojas ... Joan Maurel
Published: September 23, 2025 Explor Target Antitumor Ther. 2025;6:1002337
850 22 0
Open Access Review
Genetic and epigenetic landscape of O6-methylguanine-DNA methyltransferase (MGMT): implications for DNA repair and cancer therapeutics
Shishir Singh ... Atar Singh Kushwah
Published: August 28, 2025 Explor Target Antitumor Ther. 2025;6:1002335
This article belongs to the special issue Advances in Cancer Genomics and Therapeutic Targets
1786 31 0
Open Access Review
Inflammatory signatures across four photon radiotherapy and proton radiotherapy: mechanisms, mitigation, and quality of life impact
Yuting Sheng ... Yujiang Fang
Published: August 28, 2025 Explor Target Antitumor Ther. 2025;6:1002334
1098 21 0
Open Access Review
Improvement of the sensitivity of circulating tumor DNA-based liquid biopsy: current approaches and future perspectives
Ekaterina S. Kuligina ... Evgeny N. Imyanitov
Published: August 08, 2025 Explor Target Antitumor Ther. 2025;6:1002333
5463 116 0
Open Access Original Article
Retracted: Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies
Rolla Al-Shalabi ... Nozlena Abdul Samad
Published: July 27, 2025 Explor Target Antitumor Ther. 2025;6:1002332
2142 67 0
Open Access Original Article
Novel kinase-activating genetic events in non-small cell lung carcinomas
Elena V. Preobrazhenskaya ... Evgeny N. Imyanitov
Published: July 09, 2025 Explor Target Antitumor Ther. 2025;6:1002330
1245 16 0
Open Access Review
Dysbiosis and colorectal cancer: conducive factors, biological and molecular role, and therapeutic prospectives
Gurkaranjot Singh ... Vikrant Rai
Published: June 27, 2025 Explor Target Antitumor Ther. 2025;6:1002329
2734 45 9
Open Access Review
Biliary tract cancers: advances in diagnostic and management
James Gutmans, Hiba Mechahougui
Published: June 23, 2025 Explor Target Antitumor Ther. 2025;6:1002328
2034 34 0